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Abstract
Introduction: To validate the Japanese Association for Acute Medicine (JAAM) disseminated intravascular
coagulation (DIC) scoring system in patients with severe sepsis, we conducted a multicenter, prospective study at
15 critical care centers in tertiary care hospitals.
Methods: This study included 624 severe sepsis patients. JAAM DIC was scored on the day of diagnosis of severe
sepsis (day 1) and day 4. Scores for disease severity and organ dysfunction were also evaluated.
Results: The prevalence of JAAM DIC was 46.8% (292/624), and 21% of the DIC patients were scored according to
the reduction rate of platelets. The JAAM DIC patients were more seriously ill and exhibited more severe systemic
inflammation, a higher prevalence of multiple organ dysfunction syndrome (MODS) and worse outcomes than the
non-DIC patients. Disease severity, systemic inflammation, MODS and the mortality rate worsened in accordance
with an increased JAAM DIC score on day 1. The Kaplan-Meier curves demonstrated lower 1-year survival in the
JAAM DIC patients than in those without DIC (log-rank test P <0.001). The JAAM DIC score on day 1 (odds ratio =
1.282, P <0.001) and the Delta JAAM DIC score (odds ratio = 0.770, P <0.001) were independent predictors of
28-day death. Dynamic changes in the JAAM DIC score from days 1 to 4 also affected prognoses. The JAAM DIC
scoring system included all patients who met the International Society on Thrombosis and Haemostasis overt DIC
criteria on day 1. The International Society on Thrombosis and Haemostasis scoring system missed a large number
of nonsurvivors recognized by the JAAM scoring system.
Conclusions: The JAAM DIC scoring system exhibits good prognostic value in predicting MODS and poor
prognosis in patients with severe sepsis and can detect more patients requiring treatment. Conducting repeated
daily JAAM scoring increases the ability to predict the patient’s prognosis.
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Introduction
Disseminated intravascular coagulation (DIC) is a frequent
complication of systemic inflammatory response syndrome
(SIRS) [1]. Sepsis, defined as infection-induced SIRS,
almost invariably leads to hemostatic abnormalities ran-
ging from insignificant coagulopathy to severe DIC [2].
DIC results in the widespread formation of fibrin throm-
bosis, microvascular occlusion and reduced oxygen deli-
very to cells and tissues, leading to multiple organ
dysfunction syndrome (MODS) [3]. A prospective epide-
miologic study clearly demonstrated that a clinical pro-
gression from SIRS to severe sepsis and septic shock
increases the prevalence of DIC, organ dysfunction and
the risk of death [4]. DIC associated with sepsis is there-
fore a syndrome that should be diagnosed and treated
early [5,6].
Scoring systems for DIC developed based on the Japanese
Ministry of Health and Welfare scoring system have
been independently proposed by the Japanese Associa-
tion for Acute Medicine (JAAM) and the International
Society on Thrombosis and Haemostasis (ISTH). These
scoring systems have been prospectively validated in
diverse patient populations [7-11]. Three subgroup ana-
lyses of large randomized controlled phase 3 studies
evaluating the treatment effects of anticoagulant drugs
in patients with severe sepsis used the JAAM and ISTH
DIC scoring systems for the diagnosis of DIC [12-14].
Both the JAAM and ISTH scoring systems were effec-
tively used to diagnose DIC and select proper patient
groups who require DIC treatment, although some modi-
fications were made to the latter system. Three recently
published guidelines for the diagnosis and management
of DIC variably recommend the JAAM and ISTH DIC
scoring systems based on literature reviews and analyses
[15-17].
DIC is not a disease in itself, but rather a syndrome
that always develops secondary to various underlying
disorders. DIC scoring systems are therefore usually
validated in heterogeneous groups of patients, which
may result in different evaluations of DIC diagnostic
properties and recommendations in the scoring systems.
In the present study, the JAAM Sepsis Registry Study
Group prospectively validated the JAAM DIC scoring
system in patients with severe sepsis, the leading cause
of DIC, in a critical care setting.
Materials and methods
This study was prospectively conducted by the JAAM
Sepsis Registry Study Group as part of a multicenter
prospective survey of severe sepsis in Japan [18]. Both
the JAAM and the Ethics Committees of the participating
hospitals approved the study protocol. The data collection
was performed as a routine clinical workup without any
interventions, and the data management and statistical
analyses were processed anonymously. For these reasons,
both the JAAM and the Ethics Committees of each
hospital waived written informed consent.
Patients
The patients recruited for this prospective validation
study were registered at 15 critical care centers in tertiary
care hospitals during a 1-year period from 1 June 2010
to 31 May 2011. All patients admitted to the ICU with-
out any exclusion criteria were enrolled when they were
diagnosed as having severe sepsis.
Definitions
SIRS, sepsis, severe sepsis and septic shock were defined
according to the American College of Chest Physicians/
Society of Critical Care Medicine consensus conference
and its revised version published in 2003 [19,20]. The dis-
ease severity of the patients was evaluated according to
the Acute Physiology and Chronic Health Evaluation
(APACHE) II score at the time of enrollment [21]. Organ
dysfunction was assessed according to the Sequential
Organ Failure Assessment (SOFA) score [22]. MODS
was defined as a SOFA score ≥12 [22]. A DIC diagnosis
was made on the basis of the JAAM DIC diagnostic cri-
teria (Table 1) [8,10]. The Delta JAAM DIC score was
calculated using the day 1 JAAM DIC score minus the
day 4 JAAM DIC score. Overt DIC scores based on the
ISTH scoring system were also calculated (Table 2) [9].
ISTH overt DIC was defined as JAAM DIC patients who
simultaneously met the ISTH overt DIC criteria on day 1
in the present study. The fibrin/fibrinogen degradation
Table 1 Scoring system for disseminated intravascular





0 to 2 0
Platelet counts
<80 × 109/l or >50% decrease within 24 hours 3
≥80 <120 × 109/l or >30% decrease within 24 hours 1
≥120 × 109/l 0





≥10 <25 mg/l 1
<10 mg/l 0
Diagnosis
Disseminated intravascular coagulation ≥4
SIRS, systemic inflammatory response syndrome.
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product (FDP) was used as the fibrin-related marker for
the ISTH criteria. No increase, moderate increase and
strong increase were defined as FDP <10, 10 ≤ FDP <25,
and FDP ≥25 mg/l, respectively. When the total score was
≥4 and ≥5, a diagnosis was established using the JAAM
and ISTH criteria, respectively. The outcome measures
were the 28-day and hospital all-cause mortality rates.
Data sampling
Prospective blood sampling was performed on admission
to the ICU and daily thereafter as part of a routine clinical
and laboratory workup using established standard labora-
tory techniques. APACHE II, SOFA, SIRS and both the
JAAM and ISTH DIC scores were assessed, and the plate-
let counts and coagulation variables necessary to diagnose
DIC were collected on the day of enrollment (day 1).
Evaluation of the SOFA, SIRS and both the JAAM and
ISTH DIC scores on day 4 was also recorded.
Statistical analysis
All measurements are expressed as the mean ± standard
deviation. The IBM SPSS 20.0 for MAC OSX software
program (IBM Japan, Tokyo, Japan) was used for the sta-
tistical analyses and calculations. Comparisons between
two groups were made with the unpaired Student’s t test
for parametric data or Mann-Whitney’s U-test for non-
parametric data, and either the chi-square test or Fisher’s
exact test was used when required. To compare multiple
groups, a factorial analysis of variance with the post-hoc
Dunnett’s t test and multiple chi-square tests were applied.
The relationships between dependent and independent
variables were analyzed using a stepwise logistic regression
analysis with backward elimination based on the likelihood
ratio. The results of the regressions were reported as the
odds ratios and 95% confidence intervals. Survival curves
were derived according to the Kaplan-Meier method and
compared using the log-rank test. Differences with P <0.05
were considered statistically significant.
Results
Baseline characteristics and outcomes of the patients
During the 1-year registration period, a total of 14,417
patients were admitted to 15 critical care centers, of
whom 624 (4.3%) patients were diagnosed as having
severe sepsis and were enrolled in the study. Of these
624 patients, 292 (46.8%) were diagnosed with DIC
according to the JAAM DIC scoring system. As shown
in Table 3, the JAAM DIC patients exhibited a higher
prevalence of septic shock and positive blood cultures,
in addition to higher SIRS, APACHE II and SOFA
scores, which resulted in a greater incidence of MODS
and poorer prognoses compared with patients without
DIC. We further confirmed that there was a significant
difference in the JAAM DIC scores on day 1 between
Table 2 Scoring system for overt disseminated
intravascular coagulation proposed by International
Society on Thrombosis and Haemostasis
Score
Platelet counts
<50 × 109/l 2
≥50 <100 × 109/l 1













If >5, compatible with overt DIC; repeat scoring daily
If <5, suggestive (not affirmative) for nonovert DIC; repeat
next 1 to 2 days.
DIC, disseminated intravascular coagulation. aFor example, soluble fibrin
monomers/fibrin degradation products.
Table 3 Characteristics of JAAM DIC and non-DIC patients







Age (years) 69 ± 18 69 ± 15 0.575
Gender (male/female) 181/111 210/122 0.744




JAAM DIC score 5.6 ± 1.3 1.9 ± 0.9 <0.001
Platelet counts (× 109/l) 89 ± 88 215 ± 111 <0.001
Prothrombin time
(seconds)
19.5 ± 9.5 16.1 ± 5.1 <0.001
Prothrombin time ratio 1.63 ± 0.64 1.40 ± 0.56 <0.001
Fibrinogen (g/l) 3.96 ± 1.96 4.83 ± 1.99 <0.001
FDP (mg/l) 62.5 ± 104.7 10.6 ± 6.7 <0.001
SIRS score 3.3 ± 0.8 3.1 ± 0.9 0.007
APACHE II score 25.2 ± 8.5 21.9 ± 7.9 <0.001
SOFA score 10.6 ± 3.8 6.7 ± 3.3 <0.001







APACHE, Acute Physiology and Chronic Health Evaluation; DIC, disseminated
intravascular coagulation; FDP, fibrin/fibrinogen degradation products; JAAM,
Japanese Association for Acute Medicine; MODS, multiple organ dysfunction
syndrome; SIRS, Systemic Inflammatory Response Syndrome; SOFA, Sequential
Organ Failure Assessment.
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survivors (3.4 ± 2.2) and nonsurvivors (4.3 ± 2.0)
amongst all patients (P <0.001). The prevalence of
JAAM DIC was also different between survivors (201/480,
41.9%) and nonsurvivors (91/144, 63.2%) (P <0.001). The
survival curves of the two groups derived according to the
Kaplan-Meier method demonstrated that the survival rate
of the patients with JAAM DIC was significantly lower
than that of the patients without DIC (log-rank test
P <0.001).
Relationships between DIC scores, severity scores and
outcomes
We observed stepwise deterioration in the severity scores
associated with significant increases in the prevalence of
MODS and the mortality rate in accordance with an
increase in the JAAM DIC scores on day 1 from 0 to a
maximum of 8 (Table 4). In particular, the SOFA scores
on day 1, the maximum SOFA scores observed during
the study period and the prevalence of MODS increased
in parallel with the increase in the DIC scores.
The 28-day and hospital mortality rates also increased
in accordance with the increase in the JAAM DIC
scores. Furthermore, there was a notable difference in
mortality between the patients with scores of 0 to 3
(non-DIC) and those with scores ≥4 (DIC). To predict
the 28-day mortality based on the JAAM DIC score on
day 1, a receiver operating characteristic curve was con-
structed. The area under the receiver operating character-
istic curve (standard error) and the 95% confidence
interval were 0.629 (0.03) and 0.572 to 0.687 (P <0.001),
respectively. Table 5 shows that the JAAM DIC score on
day 1 (the day of diagnosis of severe sepsis) is an indepen-
dent predictor of 28-day mortality. The Delta JAAM DIC
score, defined as the day 1 score minus the day 4 score,
was also found to predict 28-day death, which indicates
that improvement of DIC is associated with better prog-
nosis of severe sepsis. Figure 1 demonstrates that the time
course of JAAM DIC - namely, improvement, deteriora-
tion and unchanging scores - significantly affects the pre-
valence of MODS and the 28-day and hospital mortality
rates in patients with severe sepsis. Newly developed and
unchanging DIC conditions clearly increased the preva-
lence of MODS and worsened both mortality rates, which
supports the results of the logistic regression analyses.
Dynamic changes in platelet counts and DIC diagnosis
In addition to a static assessment, the JAAM DIC scor-
ing system dynamically evaluates changes in platelet
counts. A 30 to 50% decrease and a ≥50% decrease in
the platelet count within 24 hours add 1 and 3 points to
the score, respectively. In the present study, 30 patients
exhibited 30 to 50% decreases in the platelet counts and
received 1 point, while 32 patients exhibited ≥50%
decreases in the platelet counts and received 3 points.
Dynamic changes in platelet counts therefore contribu-
ted to the diagnosis of DIC in 21.2% (62/292) of the
JAAM DIC patients.
JAAM DIC and ISTH overt DIC in patients with severe
sepsis
Table 6 shows a comparison between the non-DIC
patients, the JAAM DIC patients (those who met the
JAAM DIC criteria alone), and the ISTH overt DIC
patients (those who simultaneously met both the JAAM
and ISTH criteria) on day 1. The JAAM DIC scoring
system was able to diagnose and include all of the ISTH
overt DIC patients on day 1. Figure 2 represents the
relationship between the JAAM DIC and ISTH overt
DIC patients. When using the ISTH overt DIC criteria
as the gold standard for DIC diagnosis, the sensitivity
and specificity of the JAAM DIC scoring system were
100% and 65.0%, respectively. The JAAM DIC patients
who simultaneously met the ISTH overt DIC criteria
exhibited higher SOFA scores and a higher incidence of












5 (n = 105) 6 (n = 59) 7 (n = 19) 8 (n = 50)




21.8 ± 7.5 23.7 ±
8.6
23.4 ± 7.9 26.1 ± 9.1bc 25.1 ± 7.0b 25.0 ± 9.1 26.0 ± 9.2b
SIRS score 1.7 ± 0.5 2.8 ± 1.0 3.2 ± 0.7 3.4 ± 0.7 2.9 ± 1.0ad 3.3 ± 0.7ab 3.5 ± 0.5ab 2.7 ± 1.0a 3.6 ± 0.5abc








SOFA peak score during study
period










MODS (%) 42.1 32.6 37.1 54.3 55.9bc 61.9bc 72.9abcd 63.2b 76.0abcd
28-day mortality (%) 5.3 10.1 18.9 19.8 27.1b 37.1abcd 27.1ab 31.6ab 28.0ab
Hospital mortality (%) 10.5 14.6 25.2 25.9 30.5ab 43.8abcd 35.6ab 42.1ab 38.0ab
APACHE, Acute Physiology and Chronic Health Evaluation; DIC, disseminated intravascular coagulation; JAAM, Japanese Association for Acute Medicine; MODS,
multiple organ dysfunction syndrome; SIRS, Systemic Inflammatory Response Syndrome; SOFA, Sequential Organ Failure Assessment. Analyses of variance of
APACHE II, SIRS and SOFA are as follows: P <0.001, aP <0.05 versus 0, bP <0.05 versus 1, cP <0.05 versus 2, dP <0.05 versus 3.
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MODS. The results in Table 6 and Figure 2 suggest that
the ISTH overt DIC criteria missed 57 and 69 DIC
patients who will die on the 28th day and in hospital,
respectively.
Discussion
Diagnostic criteria should meet three conditions: they
should be readily available and easy to use, they should
exhibit diagnostic accuracy and they should display
prognostic value. The JAAM DIC scoring system con-
sists of SIRS criteria, platelet counts and global markers
of coagulation and fibrinolysis, is easy to use at the
bedside and is commonly available in all hospitals world-
wide. The absence of a 100% accurate gold standard for
the diagnosis of DIC is a serious limitation in the
evaluation of the diagnostic accuracy of DIC diagnostic
scoring systems. The validation of the ISTH overt DIC
scoring system adopted the opinions of two independent
experts in hemostasis and intensive care medicine as the
gold standard for the diagnosis of DIC [11]. The diagnos-
tic accuracy of the JAAM DIC scoring system has been
evaluated according to two existing systems, the Japanese
Ministry of Health and Welfare and the ISTH overt DIC
scoring systems, as the gold standard and was confirmed
to possess high sensitivity and moderate specificity for
DIC diagnosis [8]. Furthermore, the JAAM scoring sys-
tem is able to diagnose DIC earlier than the two existing
systems. The prognostic value of the JAAM scoring sys-
tem in the critical care setting has also been prospectively
confirmed in two previous studies [8,10]. These results
were obtained in diverse populations of patients with
critical illnesses.
The present study further demonstrated that the
JAAM DIC scoring system exhibits good prognostic
value in patients with severe sepsis. The patients who
met the JAAM DIC criteria on the first day of diagnosis
of severe sepsis clearly showed severe systemic inflam-
mation, a higher incidence of MODS, fewer survival
days and a higher mortality rate. These changes
occurred in parallel with increases in the JAAM DIC
scores from 0 to a maximum of 8. The logistic regres-
sion analysis revealed a higher 28-day mortality rate in
the DIC patients. The SIRS, SOFA and APACHE II
scores and the incidence of MODS were in good agree-
ment with our retrospective analysis of the JAAM scor-
ing system in patients with sepsis [23]. However, the
mortality rate of the DIC patients observed in the pre-
sent study was higher than that reported in the previous
study due to the greater severity of severe sepsis com-
pared with sepsis. In contrast to these results, Singh and
colleagues failed to discriminate between survivors and
nonsurvivors among JAAM DIC patients with sepsis
[24]. The difference may arise from the lower disease
severity (APACHE II score, 14.3 vs. 25.2; SOFA score,
8.3 vs. 10.6) and the extremely higher mortality rate
(64.3% vs. 31.2%) in their study subjects compared with
that observed in the present study.
The present study showed that in addition to static
assessment of the DIC score, dynamic changes in DIC
scores are useful for predicting the prognosis of patients
with severe sepsis. As presented in Figure 1, the prog-
noses of patients with severe sepsis worsened more sig-
nificantly in the patients who proceeded to develop new
DIC on day 4 and in those showing continuous DIC
from days 1 to 4 than in the non-DIC patients and
those recovering from DIC. A logistic regression analysis
demonstrated that the Delta JAAM DIC score is an
independent predictor of 28-day death among patients
with severe sepsis. These results suggest that performing
Figure 1 Twenty-eight-day and hospital mortality rates and
prevalence of multiple organ dysfunction syndrome on day 4.
The 28-day and hospital mortality rates and prevalence of multiple
organ dysfunction syndrome (MODS) in patients who did or did not
exhibit improvement of the Japanese Association for Acute
Medicine (JAAM) disseminated intravascular coagulation (DIC) score
on day 4: -/-, non-JAAM DIC both on days 1 and 4; +/-,
improvement of JAAM DIC on day 4; -/+, proceed to JAAM DIC on
day 4; +/+, JAAM DIC on days 1 and 4. Open bars, 28-day mortality;
hatched bars, hospital mortality; dark bars, MODS. *P <0.05 versus
-/-. †P <0.05 versus +/-. #P <0.05 versus -/+.
Table 5 Stepwise logistic regression analyses on day of







Age 1.022 0.010 1.005 to 1.040
JAAM DIC score 1.282 <0.001 1.141 to 1.439
Delta JAAM DIC score 0.770 <0.001 0.675 to 0.878
Fibrinogen 0.998 0.033 0.997 to 1.000
DIC, disseminated intravascular coagulation; JAAM, Japanese Association for
Acute Medicine. Dependent variables at step 1: age, gender JAAM DIC score,
Delta JAAM DIC score (day 1 - day 4), platelet count, prothrombin time ratio,
activated partial thromboplastin time, fibrinogen.
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repeated daily scoring, as well as early scoring, is essential
in the monitoring of severe sepsis associated with DIC
[5,9]. The results also indicate that DIC is a syndrome
that should be treated early in addition to managing
underlying severe sepsis.
Dynamic DIC scores that take into account temporal
dynamic changes in platelet counts and coagulation para-
meters have recently been proposed [25,26]. The prog-
nostic value of these scores has been assessed in patients
with severe sepsis, and the scores have been found to
provide useful prognostic information for such patients
and to help predict a poor prognosis. Although its prog-
nostic value has not been confirmed, the reduction rate
of platelets contributed to DIC diagnosis in 21% of the
patients with JAAM DIC in this study. It is therefore
necessary to be aware that, due to the wide distribution
of normal counts, the platelet counts may remain within
the normal range during the early stage of DIC. In such
situations, a continuous drop and/or the rate of decrease
in the platelet count over consecutive measurements are
more important for diagnosing DIC than are the absolute
values [8].
In the present study, the JAAM DIC scoring system was
able to diagnose all of the ISTH overt DIC patients on the
day of diagnosis of severe sepsis. The patients who met
both the JAAM and the ISTH overt DIC criteria exhibited
higher SOFA scores and more complications with MODS.
The ISTH overt DIC scoring system missed 126 (57 and
69) severe sepsis patients who will die on the 28th day or
in hospital. Similarly, the ISTH overt DIC scoring system
was not able to detect 79% of nonsurvivors with non-overt
DIC [27]. Taken together, these results indicate that the
JAAM DIC scoring system may be more useful than the
ISTH overt DIC scoring system for selecting DIC patients
with a poor prognosis as well as those requiring treatment
among the population of severe sepsis patients, which
coincides with our former results [8].
The present study primary evaluated the prognostic value
of the JAAM DIC scoring system, while the diagnostic
Table 6 Comparison between non-DIC, JAAM DIC and ISTH overt DIC on day of inclusion (day 1)
All JAAM DIC
Non-DIC (n = 332) JAAM DIC (n = 179) ISTH overt DIC (n = 113) P value
Age (years) 69 ± 18 70 ± 15 69 ± 16 0.484
Gender (male/female) 210/122 116/63 65/48 0.432
Septic shock (%) 35.5 51.4 63.7* <0.001
Positive blood culture (%) 33.9 42.7 60.2** <0.001
JAAM DIC score 1.9 ± 0.9 5.0 ± 0.9 6.7 ± 1.3*** <0.001
ISTH overt DIC score 1.3 ± 1.2 3.2 ± 0.9 5.7 ± 0.8*** <0.001
SIRS score 3.1 ± 0.9 3.2 ± 0.8 3.4 ± 0.8 0.012
APACHE II score 21.9 ± 7.8 24.6 ± 8.1 26.3 ± 9.0 <0.001
SOFA score 6.7 ± 3.3 9.9 ± 3.8 11.7 ± 3.5*** <0.001
MODS (%) 40.4 60.9 72.6* <0.001
28-day outcome (death/%) 53/16.0 57/31.8 34/30.1 <0.001
Hospital outcome (death/%) 72/21.7 69/38.5 43/38.1 <0.001
APACHE, Acute Physiology and Chronic Health Evaluation; DIC, disseminated intravascular coagulation; ISTH, International Society on Haemostasis and
Thrombosis; JAAM, Japanese Association for Acute Medicine; MODS, multiple organ dysfunction syndrome; SIRS, Systemic inflammatory response syndrome;
SOFA, Sequential Organ Failure Assessment. P values are between three groups. ISTH overt DIC refers to the patients meeting both the JAAM and the ISTH overt
DIC criteria. *P <0.05, **P <0.01, ***P <0.001 versus JAAM DIC.
Figure 2 Relationships between disseminated intravascular
coagulation scoring systems. Japanese Association for Acute
Medicine (JAAM) disseminated intravascular coagulation (DIC) and
International Society on Haemostasis and Thrombosis (ISTH) overt
DIC refer to JAAM DIC patients who met only the JAAM DIC criteria
and the JAAM DIC patients who simultaneously met the ISTH overt
DIC criteria on day 1, respectively. The numerators in the fractions
indicate the patients who died on day 28 (upper) and in hospital
(bottom). The ISTH overt DIC scoring system missed dozens of DIC
patients on day 1, who would eventually die.
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accuracy was not assessed due to the lack of a gold
standard for the DIC diagnosis. However, we confirmed
the high sensitivity and moderate specificity of the
JAAM scoring system using the ISTH overt DIC criteria
as the gold standard. The ISTH overt DIC criteria may
be too strict to select the patients who will eventually
die and may require the assistance of a non-overt DIC
scoring system [9]. We believe that these results indirectly
indicate the DIC diagnostic accuracy of the JAAM DIC
diagnostic algorithm in the early phase of severe sepsis in
a critical care setting.
This study does have limitations. The methods used for
the measurement of the FDP were not unified between
the participating hospitals in the present study. Differences
in the ranges of the FDP levels between the hospitals were
also not considered. These limitations might have intro-
duced a bias in the results of the present study.
Conclusions
In the critical care setting, the JAAM DIC scoring system
exhibited superior prognostic value in predicting MODS
and poor prognoses in patients with severe sepsis. The
JAAM DIC scoring system is able to select more patients
with DIC who require treatment and are near death than
the ISTH overt DIC scoring system. In addition to con-
ducting a static assessment of the DIC score, scoring
should proceed daily in order to evaluate the severity and
development of DIC and to predict the patient’s prognosis.
Dynamic scoring of platelet counts in the JAAM DIC sco-
ring system in part contributes to the sensitivity of this
system in the diagnosis of DIC.
Key messages
• The JAAM DIC scoring system exhibits good prognostic
value in predicting MODS and poor prognosis in patients
with severe sepsis.
• The JAAM DIC scoring system can detect more
patients requiring DIC treatment in patients with severe
sepsis.
• Conducting repeated daily JAAM scoring increases
the ability to predict the prognosis of the patients with
severe sepsis.
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